A phase 3 trial evaluating Moderna’s investigational seasonal influenza vaccine, mRNA-1010, found the messenger RNA ...
LUCENT-3 trial open-label extension data show 63.5% of adults with ulcerative colitis administered mirikizumab (Omvoh) who ...
Guselkumab (Tremfya) showed higher 24-week fistula remission than placebo in adults with perianal fistulizing Crohn disease.
Lastly, a broader view of clinical outcomes and operational insights is a cornerstone to product value translation. Gathering ...
On the heels of FDA’s clearance, the company plans to begin a Phase Ib/IIa trial evaluating CK0802 in patients who have ...
In a recent video interview with Applied Clinical Trials, Hal Green, senior solution architect and life sciences vertical ...
Execution instability often originates in strategy timing rather than study conduct, which sponsors can correct by ...
In this video interview, Hal Green, senior solution architect and life sciences vertical lead EMEA at Loftware, discusses why ...
As the use of digital tools continues to expand within clinical research, effective data management for eCOA systems is more important than ever. From initial design and system setup to ongoing ...
In this video interview, Hal Green, senior solution architect and life sciences vertical lead EMEA at Loftware, traces how ...
This evidence gap creates real challenges for pregnant women managing health conditions who may choose or be advised to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results